首页> 美国卫生研究院文献>Materials >Do Dental Resin Composites Accumulate More Oral Biofilms and Plaque than Amalgam and Glass Ionomer Materials?
【2h】

Do Dental Resin Composites Accumulate More Oral Biofilms and Plaque than Amalgam and Glass Ionomer Materials?

机译:牙科树脂复合材料比汞齐和玻璃离子聚合物材料积累的口腔生物膜和菌斑更多吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A long-time drawback of dental composites is that they accumulate more biofilms and plaques than amalgam and glass ionomer restorative materials. It would be highly desirable to develop a new composite with reduced biofilm growth, while avoiding the non-esthetics of amalgam and low strength of glass ionomer. The objectives of this study were to: (1) develop a protein-repellent composite with reduced biofilms matching amalgam and glass ionomer for the first time; and (2) investigate their protein adsorption, biofilms, and mechanical properties. Five materials were tested: A new composite containing 3% of protein-repellent 2-methacryloyloxyethyl phosphorylcholine (MPC); the composite with 0% MPC as control; commercial composite control; dental amalgam; resin-modified glass ionomer (RMGI). A dental plaque microcosm biofilm model with human saliva as inoculum was used to investigate metabolic activity, colony-forming units (CFU), and lactic acid production. Composite with 3% MPC had flexural strength similar to those with 0% MPC and commercial composite control (p > 0.1), and much greater than RMGI (p < 0.05). Composite with 3% MPC had protein adsorption that was only 1/10 that of control composites (p < 0.05). Composite with 3% MPC had biofilm CFU and lactic acid much lower than control composites (p < 0.05). Biofilm growth, metabolic activity and lactic acid on the new composite with 3% MPC were reduced to the low level of amalgam and RMGI (p > 0.1). In conclusion, a new protein-repellent dental resin composite reduced oral biofilm growth and acid production to the low levels of non-esthetic amalgam and RMGI for the first time. The long-held conclusion that dental composites accumulate more biofilms than amalgam and glass ionomer is no longer true. The novel composite is promising to finally overcome the major biofilm-accumulation drawback of dental composites in order to reduce biofilm acids and secondary caries.
机译:牙科复合材料的长期缺点是,与汞齐和玻璃离聚物修复材料相比,它们能积聚更多的生物膜和斑块。非常需要开发一种新的复合材料,该复合材料具有减少的生物膜生长,同时避免了汞齐的非美学和玻璃离聚物的低强度。这项研究的目的是:(1)首次开发出具有减少的生物膜,与汞齐和玻璃离聚物匹配的蛋白质排斥复合材料; (2)研究它们的蛋白质吸附,生物膜和机械性能。测试了五种材料:一种新的复合材料,其中包含3%的蛋白质排斥性2-甲基丙烯酰氧基乙基磷酰胆碱(MPC);以0%MPC为对照的复合材料;商业复合控制;牙科用汞合金树脂改性的玻璃离聚物(RMGI)。以人类唾液为接种物的牙菌斑缩微生物膜模型用于研究代谢活性,菌落形成单位(CFU)和乳酸产生。含3%MPC的复合材料的弯曲强度与含0%MPC和市售复合材料对照的复合材料的弯曲强度相似(p> 0.1),远大于RMGI(p <0.05)。具有3%MPC的复合材料的蛋白质吸附仅为对照复合材料的1/10(p <0.05)。具有3%MPC的复合材料的生物膜CFU和乳酸比对照复合材料低得多(p <0.05)。具有3%MPC的新型复合材料上的生物膜生长,代谢活性和乳酸降低至低水平的汞齐和RMGI(p> 0.1)。综上所述,一种新的具有蛋白质排斥性的牙科树脂复合材料首次将口腔生物膜的生长和产酸降低到了低水平的非美学汞合金和RMGI。长期以来一直存在的结论是,牙科复合材料比汞齐和玻璃离聚物能够积累更多的生物膜。新型复合材料有望最终克服牙科复合材料的主要生物膜富集缺点,以减少生物膜酸和继发龋齿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号